This article is only available in the PDF format. Download the PDF to view the article, as well as its associated figures and tables.
The first report of the Macular Photocoagulation Study in this issue is an important event. For the first time, a method of treatment of certain types of senile macular degeneration has been proved. Ophthalmologists and their patients will be heartened to hear of the positive results of this prospective randomized cooperative clinical trial.
See p 912.
There are certain caveats. Laser treatment to all types of senile macular degeneration was not tested or proved to be of benefit. It would be a distortion of the careful design of this study and a disservice to patients with this disease if we do not apply the study's results carefully and precisely.The positive results are limited to patients older than 50 years who have a visual acuity of 20/100 or better and with a subretinal neovascular membrane at least 200 μm from the center of the fovea. Practically, this means a subretinal
Watzke RC. Laser Photocoagulation of Senile Macular Degeneration. Arch Ophthalmol. 1982;100(6):911. doi:10.1001/archopht.1982.01030030919002
Coronavirus Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: